Stock OCUP OCUPHIRE PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Ocuphire Pharma, Inc.

Equities

OCUP

US67577R1023

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.68 USD -.--% Intraday chart for Ocuphire Pharma, Inc. -4.55% -44.19%
May. 10 Ocuphire Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 11 Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
OCUPHIRE PHARMA, INC. Stock Ocuphire Pharma, Inc.
 43.55M - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
 318B
ABBVIE INC. Stock AbbVie Inc.
 285B
  1. Stock Market
  2. Equities
  3. OCUP Stock
  4. Charts Ocuphire Pharma, Inc.
  5. Sector Chart